ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Entrada Therapeutics Inc

Entrada Therapeutics Inc (TRDA)

7,95
-0,18
(-2,21%)
Geschlossen 22 April 10:00PM
7,95
0,00
(0,00%)
Nach Börsenschluss: 1:50AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
7,95
Gebot
3,20
Fragen
9,49
Volumen
276.209
7,88 Tagesbereich 8,185
7,10 52-Wochen-Bereich 21,79
Marktkapitalisierung
Handelsende
8,13
Handelsbeginn
7,98
Letzte Trade
1
@
7.95
Letzter Handelszeitpunkt
Finanzvolumen
US$ 2.214.599
VWAP
8,0178
Durchschnittliches Volumen (3 Mio.)
129.804
Ausgegebene Aktien
37.594.630
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
4,57
Gewinn pro Aktie (EPS)
1,75
Erlöse
210,78M
Nettogewinn
65,63M

Über Entrada Therapeutics Inc

Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, an... Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Entrada Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TRDA. The last closing price for Entrada Therapeutics was US$8,13. Over the last year, Entrada Therapeutics shares have traded in a share price range of US$ 7,10 to US$ 21,79.

Entrada Therapeutics currently has 37.594.630 shares in issue. The market capitalisation of Entrada Therapeutics is US$305,64 million. Entrada Therapeutics has a price to earnings ratio (PE ratio) of 4.57.

TRDA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.05-0.62588.3757.561747877.94029434CS
4-2.68-25.211665098810.6310.877.11665598.33862627CS
12-4.77-37.512.7214.277.112980410.48219836CS
26-9.4-54.178674351617.3521.797.112503014.14155655CS
52-4.6-36.653386454212.5521.797.112245914.88591794CS
1561.0815.72052401756.8724.385.128853214.32726102CS
260-18.55-7026.536.855.129772815.06645283CS

TRDA - Frequently Asked Questions (FAQ)

What is the current Entrada Therapeutics share price?
The current share price of Entrada Therapeutics is US$ 7,95
How many Entrada Therapeutics shares are in issue?
Entrada Therapeutics has 37.594.630 shares in issue
What is the market cap of Entrada Therapeutics?
The market capitalisation of Entrada Therapeutics is USD 305,64M
What is the 1 year trading range for Entrada Therapeutics share price?
Entrada Therapeutics has traded in the range of US$ 7,10 to US$ 21,79 during the past year
What is the PE ratio of Entrada Therapeutics?
The price to earnings ratio of Entrada Therapeutics is 4,57
What is the cash to sales ratio of Entrada Therapeutics?
The cash to sales ratio of Entrada Therapeutics is 1,42
What is the reporting currency for Entrada Therapeutics?
Entrada Therapeutics reports financial results in USD
What is the latest annual turnover for Entrada Therapeutics?
The latest annual turnover of Entrada Therapeutics is USD 210,78M
What is the latest annual profit for Entrada Therapeutics?
The latest annual profit of Entrada Therapeutics is USD 65,63M
What is the registered address of Entrada Therapeutics?
The registered address for Entrada Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Entrada Therapeutics website address?
The website address for Entrada Therapeutics is www.entradatx.com
Which industry sector does Entrada Therapeutics operate in?
Entrada Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
UPXIUpexi Inc
US$ 9,83
(328,32%)
100,38M
SHFSSHF Holdings Inc
US$ 4,17
(87,00%)
43,5M
MLGOMicroAlgo Inc
US$ 11,84
(74,63%)
78,43M
MKDWMKDWELL Tech Inc
US$ 0,4027
(73,35%)
40,8M
MTENMingteng International Corporation Inc
US$ 6,24
(47,87%)
317,66k
AIEVThunder Power Holdings Inc
US$ 0,0502
(-62,87%)
6,25M
LXEHLixiang Education Holding Company Ltd
US$ 2,88
(-57,89%)
1,57M
AREBAmerican Rebel Holdings Inc
US$ 2,38
(-53,88%)
11,97M
SXTCChina SXT Pharmaceuticals Inc
US$ 1,029
(-52,36%)
1,66M
RTCBaijiayun Group Ltd
US$ 0,1862
(-49,68%)
7,75M
DMNDamon Inc
US$ 0,0041
(20,59%)
621,47M
NVDANVIDIA Corporation
US$ 96,91
(-4,51%)
288,68M
STSSSharps Technology Inc
US$ 0,0319
(-0,31%)
162,99M
RSLSReShape Lifesciences Inc
US$ 0,383
(23,67%)
152,04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 6,7771
(-11,64%)
151,31M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock